Followers | 3315 |
Posts | 33124 |
Boards Moderated | 1 |
Alias Born | 06/29/2011 |
Saturday, November 17, 2012 3:20:35 PM
Revolutions Medical Signs Distribution Agreement With McKesson
Date : 11/16/2012 @ 1:32PM
Source : MarketWire
Stock : Revolutions Medical Corp. (QB) (RMCP)
Quote : 0.095 0.015 (18.75%) @ 4:35PM
Revolutions Medical Signs Distribution Agreement With McKesson
Alert
Revolutions Medical Corp. (QB) (USOTC:RMCP)
Intraday Stock Chart
Today : Saturday 17 November 2012
Revolutions Medical Corporation (OTCQB: RMCP) announced today that the Company has entered into a vendor and distribution agreement with McKesson Corporation ("McKesson") for the distribution of the Company's RevVac™ auto-retractable vacuum safety syringe in the United States healthcare market. McKesson is one of the leading medical-surgical supply and distribution companies in the United States, while also serving as one of the country's largest pharmaceutical distributors, supplying more than 40,000 pharmacy locations across the U.S. Pursuant to the terms of the vendor and distribution agreement, the RevVac™ auto-retractable vacuum safety syringe is now available to over 550 McKesson sales representatives through their distribution network and order processing system.
Ron Wheet, the Company's Chief Executive Officer and Chairman, stated, "Since introducing the RevVac™ safety syringe to the U.S. health care market in the second quarter 2012, the Company has considered several available options to best manage the roll out of our product. We are very pleased to have the RevVac™ safety syringe distributed by McKesson, one of the best names in health care quality in the world. We believe this relationship will complement our additional sales efforts with MedPro Associates."
About Revolutions Medical Corporation
Revolutions Medical Corporation is a safety medical device and software application company. Its proprietary technologies and products include: the RevVac™ safety syringe, safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS) and prefilled vacuum auto-retraction safety syringes.
For additional information, please visit Revolutions Medical corporate website:
http://www.revolutionsmedical.com/
To be added to the Revolutions Medical investor email list, please email:
investment@revolutionsmedical.com with RMCP in the subject line.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
CONTACT:
Revolutions Medical Corporation
Investor Relations
Tel.: (843) 606-9461
Recent MCK News
- McKesson Corporation Declares Quarterly Dividend • Business Wire • 04/24/2024 12:00:00 PM
- McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date • Business Wire • 03/27/2024 08:10:00 PM
- GameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More News • IH Market News • 03/27/2024 10:54:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:24:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:54:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/13/2024 04:03:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 10:49:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 10:08:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 10:07:57 PM
- McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance • Business Wire • 02/07/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:05:29 PM
- U.S. Index Futures Dip Ahead of Key Earnings Reports, Oil Prices Climb • IH Market News • 02/07/2024 11:17:09 AM
- McKesson Corporation Declares Quarterly Dividend • Business Wire • 02/01/2024 01:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 09:52:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 01:04:07 PM
- McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/09/2024 01:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:07:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:51:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/03/2024 04:11:34 PM
- McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference • Business Wire • 12/27/2023 09:10:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/13/2023 07:54:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:07:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:03:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/07/2023 05:16:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2023 02:22:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM